Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer
Clinical trial NCT02050178 · COMPLETED
Trial details
- NCT number
- NCT02050178
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2017-06-15
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.